Industry

These nursing professionals can now easily access the Oola Lifestyle Framework SACRAMENTO–(BUSINESS WIRE)–Groundbreaking self-development company Oola recently formed a partnership with the Association of California Nurse Leaders (ACNL). This unique relationship provides nurses within the organization with discounted access to the digital Oola Lifestyle Framework as well as other self-improvement digital courses offered by Oola. … [Read more…]

ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recognizes World Alzheimer’s Month and the extraordinary progress in diagnosing the disease. The company’s DISCERN™ test assesses the factors directly related to the formation of synaptic connections in the brain impacting … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type, PET Product, and End User” report has been added to ResearchAndMarkets.com’s offering. The global prostate cancer nuclear medicine diagnostics market is expected to grow from US$ 720.12 million in 2022 to US$ 1,315.66 million by 2028. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “External Defibrillator Market Research Report: By Patient Type, End User – Global Industry Revenue Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. One of the key reasons behind the growth of the global external defibrillator market is the rise in the prevalence of cardiovascular diseases (CVDs). As a result, the revenue … [Read more…]

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to two upcoming webcasts of Pfizer discussions at healthcare conferences: Mikael Dolsten, Chief Scientific Officer, President, Worldwide Research, Development and Medical, at Citi’s 17th Annual BioPharma Conference on Wednesday, September 7, 2022 at 10:30 a.m. EDT; and David Denton, … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–RudderStack today announced HIPAA compliance, giving healthcare companies an easier way to manage and protect customer data. As a compliant solution provider, RudderStack can sign a Business Associate Agreement (BAA) with healthcare customers. RudderStack enables teams to collect, transform, and activate customer data across their stack, leveraging their own cloud data warehouse as … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. MARKET OUTLOOK This report states that the Alzheimer’s disease therapeutics and diagnostics market in the Asia-Pacific would fast progress with a CAGR of 12.18% over the forecast duration from 2022 to 2028. Japan, India, South Korea, China, Australia … [Read more…]

CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccine The Omicron BA.1-adapted bivalent COVID-19 vaccine combines 15-µg of mRNA encoding the SARS-CoV-2 wild-type spike protein which is in the Original Pfizer-BioNTech COVID-19 Vaccine with 15-µg of mRNA encoding the spike protein of the Omicron … [Read more…]

As Flu Season Approaches and COVID-19 Continues to Spread Throughout the U.S., GenBody America Updates Their Test Kits to Include Individual Reagent Bottles — Significantly Enhancing Ease of Testing JURUPA VALLEY, Calif.–(BUSINESS WIRE)–#AntigenTestKits—GenBody America, LLC, the U.S. affiliate of GenBody, Inc., a South Korean manufacturer of rapid diagnostic tests and reagents for point-of-care applications for … [Read more…]

New silicon-based drugs made with Fuzionaire’s proprietary alkali metal catalyst platform could offer improved efficacy and reduced toxicity THE WOODLANDS, Texas–(BUSINESS WIRE)–Fuzionaire, Inc. today announced a collaborative research agreement with McGill University that will leverage the company’s proprietary alkali metal catalyst platform in creating novel heterocyclic, biologically active, silicon-containing scaffolds and new silicon-based drug candidates. … [Read more…]